99 related articles for article (PubMed ID: 25774475)
1. The use of granulocyte-macrophage colony-stimulating factor in melanoma treatment.
Hodi FS
Clin Adv Hematol Oncol; 2015 Feb; 13(2):84-6. PubMed ID: 25774475
[No Abstract] [Full Text] [Related]
2. GM-CSF/Ipilimumab combination extends melanoma survival.
Cancer Discov; 2013 Jul; 3(7):OF6. PubMed ID: 23847381
[TBL] [Abstract][Full Text] [Related]
3. Combination Immunotherapy for Melanoma.
Kaufman HL
JAMA Oncol; 2015 Jun; 1(3):387-8. PubMed ID: 26181189
[No Abstract] [Full Text] [Related]
4. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
[No Abstract] [Full Text] [Related]
5. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
Disis ML
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
[No Abstract] [Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer.
Wolf M; Klausmann M; Havemann K
Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147
[No Abstract] [Full Text] [Related]
7. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
8. Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
O'Day SJ; Boasberg PD; Piro L; Kristedja TS; Wang HJ; Martin M; Deck R; Ames P; Shinn K; Kim H; Fournier P; Gammon G
Clin Cancer Res; 2002 Sep; 8(9):2775-81. PubMed ID: 12231516
[TBL] [Abstract][Full Text] [Related]
9. Combination boosts survival for metastatic melanoma.
Tanday S
Lancet Oncol; 2014 Dec; 15(13):e592. PubMed ID: 25499292
[No Abstract] [Full Text] [Related]
10. Needed: qualitative improvement in antisarcoma therapy.
Edmonson JH
J Clin Oncol; 1995 Jul; 13(7):1531-3. PubMed ID: 7602340
[No Abstract] [Full Text] [Related]
11. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute myelogenous leukaemia.
Löwenberg B
J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
[TBL] [Abstract][Full Text] [Related]
13. Dose intensity in small cell lung cancer.
Thatcher N; Lee SM; Woll PJ; Middleton M; Anderson H; Burt P; Stout R
Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057
[TBL] [Abstract][Full Text] [Related]
14. Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
Rosell R; Gómez-Codina J; Anton A; Sánchez JJ; Vadell C
Semin Oncol; 1994 Feb; 21(1 Suppl 1):48-53. PubMed ID: 8153657
[No Abstract] [Full Text] [Related]
15. The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract.
de Mulder PH; Sternberg CN; van Oosterom AT; Fossa SD
Semin Oncol; 1994 Feb; 21(1 Suppl 1):65-9. PubMed ID: 7512278
[No Abstract] [Full Text] [Related]
16. Clinical trials referral resource. Protocols for elderly patients with acute myeloid leukemia.
Cheson BD
Oncology (Williston Park); 1991 Nov; 5(11):61-2, 65. PubMed ID: 1837230
[No Abstract] [Full Text] [Related]
17. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
Willemse PH; Boonstra H; de Vries EG
Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
[No Abstract] [Full Text] [Related]
19. Metastatic colorectal cancer: advances in biochemical modulation and new drug development.
Meropol NJ; Creaven PJ; Petrelli NJ
Semin Oncol; 1995 Oct; 22(5):509-24. PubMed ID: 7570061
[No Abstract] [Full Text] [Related]
20. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
